SCHEMBL4555876

SCHEMBL4555876

O=S(=O)(c1cc(F)cc(F)c1)N1CCCCCC1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.61
PKM P14618 1/20 0.57
KMT2A Q03164 1/20 0.57
MAPT P10636 2/20 0.53
ALDH1A1 P00352 4/20 0.51
LMNA P02545 4/20 0.51
HTT P42858 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
CYP3A4 P08684 1/20 0.51
MITF O75030 1/20 0.51
GAA P10253 1/20 0.51
TSHR P16473 3/20 0.50
MCOLN3 Q8TDD5 2/20 0.50
POLB P06746 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
THRB P10828 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21464610 0.85 USP2 (0.48) USP2PKMKMT2AMAPTALDH1A1
SCHEMBL26144787 0.84 USP2 (0.47) USP2PKMKMT2AMAPTALDH1A1
SCHEMBL11178574 0.84 MAPT (0.60) USP2KMT2AMAPTLMNAHTT
SCHEMBL28308929 0.82 ALDH1A1 (0.67) USP2PKMKMT2AMAPTALDH1A1
SCHEMBL31684030 0.82 ALDH1A1 (0.67) USP2PKMKMT2AMAPTALDH1A1
SCHEMBL4555427 0.82 ALDH1A1 (0.67) USP2PKMKMT2AMAPTALDH1A1
SCHEMBL7096080 0.80 USP2 (0.80) USP2PKMKMT2AMAPTALDH1A1
SCHEMBL4554939 0.80 USP2 (0.80) USP2PKMKMT2AMAPTALDH1A1
SCHEMBL14489550 0.79 ALDH1A1 (0.69) PKMKMT2AMAPTALDH1A1LMNA
SCHEMBL8217672 0.79 PKM (0.53) USP2PKMKMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134714-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY Biovitrum AB (publ) (SE) 2009-12-23 EP disclosed
WO-2008110598-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY BIOVITRUM AB (PUBL) (SE) 2008-09-18 WO disclosed